Go Pro
→ China's dominance in rare earth processing sparks new defense rules (From The Tomorrow Investor) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$233.75
-4.5%		$234.01
$171.18
▼
$248.84
$26.02B0.55956,120 shs199,733 shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$176.67
+1.6%		$161.41
$55.38
▼
$183.51
$23.59B1.572.25 million shs62,531 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$312.27
-2.7%		$315.41
$244.52
▼
$341.80
$25.42B0.88682,800 shs78,237 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$77.57
-0.6%		$57.63
$40.77
▼
$104.32
$13.90B3.726.10 million shs277,587 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
-0.75%+2.96%+0.19%+24.32%+33.28%
Guardant Health, Inc. stock logo
GH
Guardant Health
-3.07%+3.59%+1.86%+32.90%+193.95%
Labcorp Holdings Inc. stock logo
LH
Labcorp
+0.30%+1.91%-4.39%+24.14%+15.95%
Tempus AI, Inc. stock logo
TEM
Tempus AI
+0.24%+25.43%+7.35%+60.52%-11.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$233.75
-4.5%		$234.01
$171.18
▼
$248.84
$26.02B0.55956,120 shs199,733 shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$176.67
+1.6%		$161.41
$55.38
▼
$183.51
$23.59B1.572.25 million shs62,531 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$312.27
-2.7%		$315.41
$244.52
▼
$341.80
$25.42B0.88682,800 shs78,237 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$77.57
-0.6%		$57.63
$40.77
▼
$104.32
$13.90B3.726.10 million shs277,587 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
-0.75%+2.96%+0.19%+24.32%+33.28%
Guardant Health, Inc. stock logo
GH
Guardant Health
-3.07%+3.59%+1.86%+32.90%+193.95%
Labcorp Holdings Inc. stock logo
LH
Labcorp
+0.30%+1.91%-4.39%+24.14%+15.95%
Tempus AI, Inc. stock logo
TEM
Tempus AI
+0.24%+25.43%+7.35%+60.52%-11.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.54
Moderate Buy$237.081.42% Upside
Guardant Health, Inc. stock logo
GH
Guardant Health
2.96
Moderate Buy$188.136.49% Upside
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.75
Moderate Buy$337.738.15% Upside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.41
Hold$69.63-10.24% Downside

Current Analyst Ratings Breakdown

Latest TEM, DGX, LH, and GH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$75.00
9/21/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$250.00 ➝ $260.00
9/21/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$350.00 ➝ $365.00
9/21/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$75.00
9/15/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
9/11/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$361.00 ➝ $380.00
9/11/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$320.00 ➝ $330.00
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$56.00 ➝ $66.00
9/10/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$210.00
9/9/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$175.00 ➝ $225.00
(Data available from 9/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$11.04B2.34$14.39 per share16.24$64.78 per share3.61
Guardant Health, Inc. stock logo
GH
Guardant Health
$982.02M24.14N/AN/A($0.79) per share-223.63
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.95B1.82$24.17 per share12.92$103.98 per share3.00
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.27B11.01N/AN/A$2.76 per share28.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$992M$9.4225.0319.532.259.18%16.01%7.27%10/20/2026 (Estimated)
Guardant Health, Inc. stock logo
GH
Guardant Health
-$416.28M-$3.49N/AN/AN/A-38.33%N/A-25.40%10/28/2026 (Estimated)
Labcorp Holdings Inc. stock logo
LH
Labcorp
$876.50M$12.0925.9215.851.826.99%16.74%7.81%10/27/2026 (Estimated)
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.44N/AN/AN/A-17.77%-50.28%-10.33%11/3/2026 (Estimated)

Latest TEM, DGX, LH, and GH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/20/2026Q3 2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.85N/AN/AN/A$3.04 billionN/A
7/30/2026Q2 2026
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.7618-$0.42+$0.3418-$0.90$314.23 million$334.98 million
7/30/2026Q2 2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.78$4.99+$0.21$3.64$3.71 billion$3.73 billion
7/30/2026Q2 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.1428-$0.04+$0.1028$0.03$379.69 million$382.49 million
7/23/2026Q2 2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.82$3.12+$0.30$2.84$2.97 billion$3.04 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.441.47%+7.34%36.52%14 Years
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.880.92%N/A23.82%N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A

Latest TEM, DGX, LH, and GH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/12/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.861.45%10/6/202610/6/202610/21/2026
7/9/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.720.86%8/28/20268/28/20269/11/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.72
1.59
1.46
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
4.03
3.71
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.69
1.80
1.53
Tempus AI, Inc. stock logo
TEM
Tempus AI
3.06
3.30
3.16

Institutional Ownership

CompanyInstitutional Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.88%
Guardant Health, Inc. stock logo
GH
Guardant Health
5.60%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
57,000110.37 million109.40 millionOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
2,506134.20 million126.68 millionNot Optionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
71,00081.10 million80.42 millionOptionable
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800180.43 million136.66 millionN/A

Recent News About These Companies

Tempus AI: High Risk, But With A Great Cause
 |  seekingalpha.comhttps://seekingalpha.com/article/4948568-tempus-ai-high-risk-but-with-a-great-cause
Tempus AI (NASDAQ:TEM) Rating Increased to Hold at The Goldman Sachs Group
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31039710
Tempus AI (NASDAQ:TEM) Upgraded by The Goldman Sachs Group to Hold Rating
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-tempus-ai-nasdaq-tem-upgraded-by-the-goldman-sachs-group-to-hold-rating-2026-09-22/
Tempus AI: Data And Applications Will Unlock More Upside
September 21 at 12:00 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4948478-tempus-ai-stock-data-applications-will-unlock-more-upside
Tempus AI, Recursion Extend Data License, Amend Fee Structure
September 21 at 11:33 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tempus-ai-recursion-extend-data-143658573.html
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
September 21 at 8:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-tempus-ai-sees-pricing-data-growth-fueling-long-term-expansion-2026-09-21/
Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target
September 21 at 6:32 PM  |  marketscreener.comM
Artificial Intelligence Stocks To Watch Now - September 21st
September 21 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-artificial-intelligence-stocks-to-watch-now-september-21st-2026-09-21/
Tempus AI: Market Is Hyping On An Uncertain Number
September 21 at 9:37 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4948316-tempus-ai-market-is-hyping-on-an-uncertain-number
Insider Selling: Tempus AI (NASDAQ:TEM) EVP Sells $221,325.00 in Stock
September 21 at 4:54 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036577
Insider Selling: Tempus AI (NASDAQ:TEM) CAO Sells $529,650.00 in Stock
September 21 at 4:54 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036572
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $16,114,000.00 in Stock
September 21 at 4:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036306
Best Artificial Intelligence Stocks To Watch Now - September 18th
September 21 at 3:02 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31035753
Tempus AI (TEM) Is Building a Heart Failure Agent That Never Sleeps
September 21 at 2:11 AM  |  insidermonkey.comhttps://www.insidermonkey.com/news/tempus-ai-tem-is-building-a-heart-failure-agent-that-never-sleeps-1840781/
Tempus Secures Up To $9.5 Million From ARPA-H To Develop Autonomous AI Agent For Heart Failure Care
September 20 at 5:04 PM  |  pulse2.comP
Ryan Fukushima Sells 700 Shares of Tempus AI (NASDAQ:TEM) Stock
September 20 at 10:00 AM  |  defenseworld.netD
Tempus AI (TEM), What Is Behind The Latest Buzz?
September 20 at 7:03 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tempus-ai-tem-behind-latest-051247679.html
Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative
September 19 at 8:46 PM  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/tempus-ai-tem-31-9-161226574.html
Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes
September 19 at 8:46 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tempus-ai-tem-unveils-whole-111421978.html
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $49,000.00 in Stock
September 19 at 7:07 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tem-insider-buying-and-selling-2026-09-19/
Tempus AI (NASDAQ:TEM) CEO Sells $49,000.00 in Stock
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-tempus-ai-nasdaq-tem-ceo-sells-4900000-in-stock-2026-09-18/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Close-up of a carbon fiber surface bearing the AV logo and a camera sensor.
AeroVironment’s $465 Million Army Laser Win Expands Its Counter-Drone Opportunity
By Ryan Hasson | September 3, 2026
Autonomous military drone with AV-style logo on the nose sitting on a runway, representing AeroVironment and the defense drone industry.
AeroVironment's Record Backlog and Earnings Beat Fuel Recovery Case
By Thomas Hughes | September 10, 2026
Illustration of an upward-trending stock chart line overlaid on a city skyline of office towers at sunset.
Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
By Nathan Reiff | August 30, 2026
Foldable Apple smartphone displayed on a table with a lit Apple logo and city skyline in the background.
Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
By Sam Quirke | August 30, 2026
NVIDIA logo displayed on a wall inside a data center with server racks and monitors visible.
NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
By Jeffrey Neal Johnson | September 3, 2026
Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$233.75 -11.13 (-4.54%)
As of 09:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Guardant Health stock logo

Guardant Health NASDAQ:GH

$176.67 +2.80 (+1.61%)
As of 09:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Labcorp stock logo

Labcorp NYSE:LH

$312.26 -8.73 (-2.72%)
As of 09:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$77.57 -0.46 (-0.59%)
As of 09:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas